Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-29

Clinical Trial Update: Impact of Topical Tranexamic Acid in Breast Reconstruction [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating topical tranexamic acid to reduce bleeding in breast reconstruction was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of California, San Francisco | Conditions: Breast Cancer | Phase 4 | Status: TERMINATED | Results posted: 2025-09-29